Coagulation factors as potential tumour markers in patients with head and neck carcinomas?;Gerinnungsfaktoren als potenzielle tumormarker bei patienten mit kopf-hals-karzinomen?

Laryngo- Rhino- Otologie

Volumn 89, Issue 10, 2010, Pages 612-615

  Greve, J ^a   Schuler, P J ^a   Bas, M ^b   Adamzik, M ^a   Brandau, S ^a   Arweiler Harbeck, D ^a   Lang, S ^a   Hoffmann, T K ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

coagulation factors; head and neck tumour; squamous cell carcinoma; thrombin antithrombin III complex; tumour markers

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; FIBRINOGEN; PLASMIN; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; TUMOR MARKER; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HUMAN; MALE; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TUMOR ABLATION;

ADULT; AGED; AGED, 80 AND OVER; ANTITHROMBIN III; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; PEPTIDE HYDROLASES; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 77958129796     PISSN: 09358943     EISSN: 14388685     Source Type: Journal    
DOI: 10.1055/s-0030-1261892     Document Type: Article

References (17)

1. Goon PK, Stanley MA, Ebmeyer J, Steinsträsser L, Upile T, Jerjes W, Bernal-Sprekelsen M, Görner M, Sudhoff HH. HPV & head and neck cancer: a descriptive update. Head Neck Oncol 2009 1 36
2. Weber A, Tannapfel A. Prognostic factors in head-neck carcinomas. HNO 2002 50 35-42
3. Petralia GA, Lemoine NR, Kakkar AK. Mechanisms of disease: the impact of antithrombotic therapy in cancer patients. Nat Clin Pract Oncol 2005 2 356-363
4. Yu JL, May L, Klement P, Weitz JI, Rak J. Oncogenes as regulators of tissue factor expression in cancer: implications for tumor angiogenesis and anti-cancer therapy. Semin Thromb Hemost 2004 30 21-30
5. Gale AJ, Gordon SG. Update on tumor cell procoagulant factors. Acta Haematol 2001 106 25-32
6. Lip GY, Chin BS, Blann AD. Cancer and the prothrombotic state. Lancet Oncol 2002 3 27-34
7. Falanga A, Donati MB. Pathogenesis of thrombosis in patients with malignancy. Int J Hematol 2001 73 137-144
8. Rickles FR, Levine M, Edwards RL. Hemostatic alterations in cancer patients. Cancer Metastasis Rev 1992 11 237-248
9. Nicolini A, Tartarelli G, Carpi A, Metelli MR, Ferrari P, Anselmi L, Conte M, Berti P, Miccoli P. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs. MCA and MCA-CA15.3 vs. CEA-TPA-CA15.3 panel in the early detection of distant metastases. BMC Cancer 2006 6 269
10. Kawamura YJ, Tokumitsu A, Mizokami K, Sasaki J, Tsujinaka S, Konishi F. First alert for recurrence during follow-up after potentially curative resection for colorectal carcinoma: CA 19-9 should be included in surveillance programs. Clin Colorectal Cancer 2010 9 48-51
11. Zacharski LR, Memoli VA, Ornstein DL, Rousseau SM, Kisiel W, Kudryk J. Tumor cell procoagulant and urokinase expression in carcinoma of the ovary. J Natl Cancer Inst 1993 85 1225-1230
12. Honegger H, Anderson N, Hewitt LA, Tullis JL. Antithrombin III profiles in malignancy, relationship to primary tumors and metastatic sites. Thromb Haemost 1981 46 500-503
13. Johnson MJ, Walker ID, Sproule MW, Conkie J. Abnormal coagulation and deep venous thrombosis in patients with advanced cancer. Clin Lab Haematol 1999 21 51-54
14. Khorana AA, Fine RL. Pancreatic cancer and thromboembolic disease. Lancet Oncol 2004 5 655-663
15. Wilkerson WR, Sane DC. Aging and thrombosis. Semin Thromb Hemost 2002 28 555-568
16. Seitz R, Rappe N, Kraus M, Immel A, Wolf M, Maasberg M, Egbring R, Pfab R, Havemann K. Activation of coagulation and fibrinolysis in patients with lung cancer: relation to tumour stage and prognosis. Blood Coagul Fibrinolysis 1993 4 249-254
17. Tricerri A, Vangeli M, Errani AR, Guidi L, Canetta M, Vaccarino M, De Santis C, Ipsevich F, Salvati F, Bartoloni C. Plasma thrombin-antithrombin complexes, latent coagulation disorders and metastatic spread in lung cancer: a longitudinal study. Oncology 1996 53 455-460